Effects of 6-week use of reduced-nicotine content cigarettes in smokers with and without elevated depressive symptoms

Nicotine and Tobacco Research

Volumn 19, Issue 1, 2017, Pages 59-67

  Tidey, Jennifer W ^a   Pacek, Lauren R ^b   Koopmeiners, Joseph S ^c   Vandrey, Ryan ^d   Nardone, Natalie ^a   Drobes, David J ^f   Benowitz, Neal L ^e   Dermody, Sarah S ^g   Lemieux, Andrine ^h   Denlinger, Rachel L ⁱ   Cassidy, Rachel ^a   al'Absi, Mustafa ^h   Hatsukami, Dorothy K ^c   Donny, Eric C ^j  

^a BROWN UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁱ BROWN UNIVERSITY   (United States)

^j UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG CRAVING; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NICOTINE REPLACEMENT THERAPY; NORMAL NICOTINE CONTENT CIGARETTE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REDUCED NICOTINE CONTENT CIGARETTE; SECONDARY ANALYSIS; SMOKING; SYMPTOM; TOBACCO DEPENDENCE; TREATMENT DURATION; ANALYSIS; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SMOKING CESSATION; TOBACCO; TOBACCO USE DISORDER; YOUNG ADULT;

NICOTINE;

ADULT; DEPRESSION; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PSYCHIATRIC STATUS RATING SCALES; SMOKING; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 85014061246     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw199     Document Type: Article

References (49)

1. Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23(e2):e147-e153. doi:10.1136/ tobaccocontrol-2013-051466
2. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606-2610. doi:10.1001/jama.284.20.2606
3. Callaghan RC, Veldhuizen S, Jeysingh T, et al. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res. 2014;48(1):102-110. doi:10.1016/j. jpsychires.2013.09.014
4. Goodwin RD, Lavoie KL, Lemeshow AR, Jenkins E, Brown ES, Fedoronko DA. Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine Tob Res. 2012;14(2):176-183. doi:10.1093/ntr/ntr165
5. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and time course of decreased risks of coronary heart disease in middleaged women. Arch Intern Med. 1994;154(2):169-175. doi:10.1001/ archinte.1994.00420020075009
6. Ameringer KJ, Leventhal AM. Applying the tripartite model of anxiety and depression to cigarette smoking: an integrative review. Nicotine Tob Res. 2010;12(12):1183-1194. doi:10.1093/ntr/ntq174
7. Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG. Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry. 2004;161(7):1224-1230. doi:10.1176/appi.ajp.161.7.1224
8. Escobedo LG, Reddy M, Giovino GA. The relationship between depressive symptoms and cigarette smoking in US adolescents. Addiction. 1998;93(3):433-440. doi:10.1046/j.1360-0443.1998.93343311.x
9. Berlin I, Covey LS. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction. 2006;101(12):1814-1821. doi:10.1111/j.1360-0443.2006.01616.x
10. Cinciripini PM, Wetter DW, Fouladi RT, et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003;71(2):292-301. doi:10.1037/0022-006X.71.2.292
11. Lukowski AV, Morris CD, Young SE, Tinkelman D. Quitline outcomes for smokers in 6 states: rates of successful quitting vary by mental health status. Nicotine Tob Res. 2015;17(8):924-930. doi:10.1093/ntr/ntu252
12. Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M. First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol. 1996;64(2):366-379. doi:10.1037/0022-006X.64.2.366
13. Leventhal AM, Greenberg JB, Trujillo MA, et al. Positive and negative affect as predictors of urge to smoke: temporal factors and mediational pathways. Psychol Addict Behav. 2013;27(1):262-267. doi:10.1037/ a0031579
14. Pang RD, Khoddam R, Guillot CR, Leventhal AM. Depression and anxiety symptoms moderate the relation between negative reinforcement smoking outcome expectancies and nicotine dependence. J Stud Alcohol Drugs. 2014;75(5):775-780. doi:10.15288/jsad.2014.75.775
15. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ. 2014;348:g1151. doi:10.1136/bmj.g1151
16. Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31:297-314. doi:10.1146/annurev. publhealth.012809.103701
17. US Congress. Family Smoking Prevention and Tobacco Control Act (H.R. 1256). Washington, DC: U.S. G.P.O.; 2009.
18. Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994;331(2):123-125. doi:10.1056/NEJM199407143310212
19. Benowitz NL, Henningfield JE. Reducing the nicotine content to make cigarettes less addictive. Tob Control. 2013;22(suppl 1):i14-i17. doi:10.1136/ tobaccocontrol-2012-050860
20. Hatsukami DK, Perkins KA, Lesage MG, et al. Nicotine reduction revisited: science and future directions. Tob Control. 2010;19(5):e1-e10. doi:10.1136/tc.2009.035584
21. Donny EC, Denlinger RL, Tidey JW, et al. Randomized trial of reducednicotine standards for cigarettes. N Engl J Med. 2015;373(14):1340- 1349. doi:10.1056/NEJMsa1502403
22. Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction. 2007;102(2):324-334. doi:10.1111/j.1360-0443.2006.01670.x
23. Benowitz NL, Dains KM, Hall SM, et al. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev. 2012;21(5):761-769. doi:10.1158/1055-9965.EPI-11-0644
24. Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P III. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2479-2485. doi:10.1158/1055-9965.EPI-07-0393
25. Hatsukami DK, Kotlyar M, Hertsgaard LA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010;105(2):343-355. doi:10.1111/j.1360-0443.2009.02780.x
26. Weinberger AH, George TP, McKee SA. Differences in smoking expectancies in smokers with and without a history of major depression. Addict Behav. 2011;36(4):434-437. doi:10.1016/j.addbeh.2010.12.024
27. Gaalema DE, Miller ME, Tidey JW. Predicted impact of nicotine reduction on smokers with affective disorders. Tob Regul Sci. 2015;1(2):154-165. doi:10.18001/TRS.1.2.5
28. Dermody SS, Donny EC. The predicted impact of reducing the nicotine content in cigarettes on alcohol use. Nicotine Tob Res. 2014;16(8):1033- 1044. doi:10.1093/ntr/ntu037
29. Kalman D, Kim S, DiGirolamo G, Smelson D, Ziedonis D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev. 2010;30(1):12-24. doi:10.1016/j.cpr.2009.08.009
30. Donny EC, Hatsukami DK, Benowitz NL, Sved AF, Tidey JW, Cassidy RN. Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation. Prev Med. 2014;68:17-22. doi:10.1016/j.ypmed.2014.06.020
31. Hatsukami DK, Benowitz NL, Donny E, Henningfield J, Zeller M. Nicotine reduction: strategic research plan. Nicotine Tob Res. 2013;15(6):1003- 1013. doi:10.1093/ntr/nts214
32. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401. doi:10.1177/014662167700100306
33. Lewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997;12(2):277- 287. doi:10.1037/0882-7974.12.2.277
34. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
35. Smith SS, Piper ME, Bolt DM, et al. Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res. 2010;12(5):489-499. doi:10.1093/ntr/ntq032
36. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063-1070. doi:10.1037/0022-3514.54.6.1063
37. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3(1):7-16. doi:10.1080/14622200020032051
38. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289-294. doi:10.1001/ archpsyc.1986.01800030107013
39. Scherer G, Engl J, Urban M, Gilch G, Janket D, Riedel K. Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul Toxicol Pharmacol. 2007;47(2):171-183. doi:10.1016/j.yrtph.2006.09.001
40. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57(1):79-115. doi:10.1124/ pr.57.1.3
41. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ, eds. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press; 1992:41-72.
42. Koenker, R. W. Quantile Regression. New York, NY: Cambridge University Press; 2005.
43. Denlinger RL, Smith TT, Murphy SE, et al. Nicotine and anatabine exposure from very low nicotine content cigarettes. Tob Reg Sci. 2016;2(2):186- 203. doi:10.18001/TRS.2.2.9
44. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: L. Erlbaum Associates; 1988.
45. Cook JW, Spring B, McChargue D. Influence of nicotine on positive affect in anhedonic smokers. Psychopharmacology (Berl). 2007;192(1):87-95. doi:10.1007/s00213-006-0688-5
46. Spring B, Cook JW, Appelhans B, et al. Nicotine effects on affective response in depression-prone smokers. Psychopharmacology (Berl). 2008;196(3):461-471. doi:10.1007/s00213-007-0977-7
47. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA, Sayette MA. Differences in negative mood-induced smoking reinforcement due to distress tolerance, anxiety sensitivity, and depression history. Psychopharmacology (Berl). 2010;210(1):25-34. doi:10.1007/s00213- 010-1811-1
48. Goodwin RD, Wall MM, Choo T, et al. Changes in the prevalence of mood and anxiety disorders among male and female current smokers in the United States: 1990-2001. Ann Epidemiol. 2014;24(7):493-497. doi:10.1016/j.annepidem.2014.01.014
49. Benowitz NL, Nardone N, Hatsukami DK, Donny EC. Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev. 2015;24(2):331-335. doi:10.1158/1055-9965